Wu K, Sachs L, Carlin R K, Siekevitz P
Brain Res. 1986 Nov;387(2):167-84. doi: 10.1016/0169-328x(86)90008-2.
Synaptic membrane (SM) and postsynaptic density (PSD) fractions isolated from the cerebral cortex (CTX) and cerebellum (CL) of the canine brain were found to contain one class of specific nitrendipine binding sites. The specific binding constants were: CTX-SM, Kd = 110 pM (Bmax = 126 fmol/mg protein); CTX-PSD, Kd = 207 pM (Bmax = 196 fmol/mg); CL-SM, Kd = 100 pM (Bmax = 65 fmol/mg); CL-PSD, Kd = 189 pM (Bmax = 80 fmol/mg). Treatment of the CTX-SM and CTX-PSD fractions with 0.5% deoxycholate and 1.0% N-lauroyl sarcosinate removed 88-91% and 42-51% of the nitrendipine binding, respectively, indicating that the major nitrendipine binding present in the SM fractions are of non-synaptic origin. Moreover, the percentages of total protein and specific nitrendipine binding removed from PSDs by these detergents were similar, indicating no preferential dissociation of the latter, and suggesting that the receptor protein is firmly bound and is probably an intrinsic component of the PSD fraction. Both Ca2+ and calmodulin were found to be important for the binding of nitrendipine to the CTX-SM and CTX-PSD fractions since: R24571, a calmodulin antagonist, was found to inhibit nitrendipine binding to the CTX-SM and CTX-PSD fractions with IC50 values of 1.1 microM and 0.9 microM, respectively; removal of Ca2+ from the CTX-SM and CTX-PSD fractions with 0.2 mM EGTA resulted in losses of specific nitrendipine binding of 80 and 90%, respectively; Ca2+ alone restored nitrendipine binding to EGTA-pretreated CTX-SM fractions and not to CTX-PSD fractions, with the latter needing both Ca2+ and calmodulin to restore nitrendipine binding; EGTA treatment removed 14-16% and 89-91% of nitrendipine bound to the CTX-SM and CTX-PSD fractions, respectively, suggesting that calmodulin (but not Ca2+) is needed to maintain the nitrendipine-nitrendipine receptor-calmodulin complex; Ca2+-reconstituted EGTA-pretreated CTX-SM fractions and the Ca2+ plus calmodulin-reconstituted EGTA-pretreated CTX-SM and CTX-PSD fractions were found to have similar binding constants to those for the corresponding native, untreated fractions; and the Ca2+/calmodulin dependency on nitrendipine binding was similar to the well-known Ca2+/calmodulin dependency on phosphorylation in EGTA-pretreated PSD fractions. It needed much less Ca2+ to saturate Ca2+/calmodulin-dependent phosphorylation of the pretreated CTX-PSD fractions than the nitrendipine binding. Yet, less calmodulin was needed to saturate nitrendipine binding than the phosphorylation.(ABSTRACT TRUNCATED AT 400 WORDS)
从犬脑的大脑皮层(CTX)和小脑(CL)分离得到的突触膜(SM)和突触后致密部(PSD)组分中,发现含有一类特异性尼群地平结合位点。特异性结合常数分别为:CTX-SM,Kd = 110 pM(Bmax = 126 fmol/mg蛋白);CTX-PSD,Kd = 207 pM(Bmax = 196 fmol/mg);CL-SM,Kd = 100 pM(Bmax = 65 fmol/mg);CL-PSD,Kd = 189 pM(Bmax = 80 fmol/mg)。用0.5%脱氧胆酸盐和1.0%N-月桂酰肌氨酸钠处理CTX-SM和CTX-PSD组分,分别去除了88 - 91%和42 - 51%的尼群地平结合,这表明SM组分中存在的主要尼群地平结合是非突触来源的。此外,这些去污剂从PSD中去除的总蛋白和特异性尼群地平结合的百分比相似,表明后者没有优先解离,这表明受体蛋白紧密结合,可能是PSD组分的固有成分。发现Ca2+和钙调蛋白对尼群地平与CTX-SM和CTX-PSD组分的结合都很重要,因为:钙调蛋白拮抗剂R24571被发现抑制尼群地平与CTX-SM和CTX-PSD组分的结合,IC50值分别为1.1 microM和0.9 microM;用0.2 mM EGTA从CTX-SM和CTX-PSD组分中去除Ca2+,分别导致特异性尼群地平结合损失80%和90%;单独的Ca2+可使尼群地平与EGTA预处理的CTX-SM组分结合恢复,但不能使CTX-PSD组分恢复,后者需要Ca2+和钙调蛋白两者才能恢复尼群地平结合;EGTA处理分别去除了与CTX-SM和CTX-PSD组分结合的尼群地平的14 - 16%和89 - 91%,这表明需要钙调蛋白(而不是Ca2+)来维持尼群地平-尼群地平受体-钙调蛋白复合物;发现Ca2+重构的EGTA预处理的CTX-SM组分以及Ca2+加钙调蛋白重构的EGTA预处理的CTX-SM和CTX-PSD组分与相应的天然未处理组分具有相似的结合常数;并且Ca2+/钙调蛋白对尼群地平结合的依赖性与EGTA预处理的PSD组分中众所周知的Ca2+/钙调蛋白对磷酸化的依赖性相似。使预处理的CTX-PSD组分的Ca2+/钙调蛋白依赖性磷酸化饱和所需的Ca2+比尼群地平结合少得多。然而,使尼群地平结合饱和所需的钙调蛋白比磷酸化少。(摘要截断于400字)